Blog post
Dante Genomics receives grant for a whole genome sequencing project to measure utility of pharmacogenomics in a real, clinical setting
– Highly coveted Innovation Grant by the Italian Government will measure impact of whole genome sequencing and pharmacogenomics starting from...
Inc. Magazine names Dante Genomics in the Top 20 of the fastest-growing companies in the U.S. and Top 5 in the Northeast
Inc. ranks Dante Genomics #19 of the 1,125 fastest-growing companies in the U.S. and regionally #2 of the 169 fastest-growing...
Dante’s whole genome sequencing lab in Dubai featured in CNN’s Decoded Series on the Human Genome Project
Dante was pleased to have CNN host Anna Stewart at its whole genome sequencing lab in Dubai to discuss her...
Dante Genomics launches Avanti Software for a plug-and-play genomic interpretation that takes minutes instead of hours
NEW YORK, March 20, 2023 (PR NEWSWIRE) -- Dante Genomics, a global leader in genomics and precision medicine, launched today the beta...
FinancialTimes selected Dante Genomics in the Top 25 European Fastest Growing Companies.
The Financial Times has published its 7th annual ranking of the 1000 fastest-growing companies in Europe. Dante Genomic ranks among...
Dante Genomics’ sequencing hub in Dubai receives ISO 15189 Medical Laboratory accreditation to bring clinical whole genome sequencing to the next billion patients
NEW YORK, January 25, 2023 (GLOBE NEWSWIRE) -- Dante Genomics, a global leader in genomics and precision medicine, announced today that their laboratory...
Dante Genomics To Present At The 41st Annual J.P. Morgan Healthcare Conference
NEW YORK, January 3, 2023 (GLOBE NEWSWIRE) — Dante Genomics, a global leader in genomics and precision medicine, is pleased to announce that...
Dante Genomics launches doctor ordered, clinical whole genome sequencing in the U.S. in partnership with 1health.io
– Dante Genomics uses the 1health.io platform to accelerate their go to market strategy and expand availability in all 50 states using...
